DINA LENTZ: Open Payments
NPI 1205571155 · COLONA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,348 in 84 payments from 14 companies in 2025. Trend: 2023 $568 · 2024 $723 · 2025 $1,348
Food & beverage: $1,236Education: $111
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 12 | $351 |
| Alkermes, Inc. | 6 | $186 |
| Neurocrine BioSciences, Inc. | 25 | $169 |
| ABBVIE INC. | 16 | $143 |
| Axsome Therapeutics, Inc. | 4 | $97 |
| Janssen Pharmaceuticals, Inc | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Lundbeck LLC | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
Products named: AUSTEDO XR, INGREZZA, VRAYLAR, LYBALVI, Auvelity, INVEGA SUSTENNA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
